Cargando…

Longitudinal relationship between albuminuria in infancy and childhood

BACKGROUND: Mildly increased albuminuria is common in the general adult population and is a strong predictor for cardiovascular events, even in otherwise healthy individuals. The underlying pathophysiological process could be endothelial dysfunction. Previously, we reported that increased albuminuri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gracchi, Valentina, van den Belt, Sophie M., Corpeleijn, Eva, de Zeeuw, Dick, Heerspink, Hiddo J. L., Verkade, Henkjan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393842/ https://www.ncbi.nlm.nih.gov/pubmed/36705757 http://dx.doi.org/10.1007/s00467-022-05850-5

Ejemplares similares

Albuminuria and markers for cardiovascular risk in 12-year-olds from the general Dutch population: a cross-sectional study
por: Gracchi, Valentina, et al.
Publicado: (2023)

How to measure and monitor albuminuria in healthy toddlers?
por: van den Belt, Sophie Marielle, et al.
Publicado: (2018)

Monitoring Kidney Function and Albuminuria in Patients With Diabetes
por: Lambers Heerspink, Hiddo J., et al.
Publicado: (2011)

Determining the optimal dose of atrasentan by evaluating the exposure‐response relationships of albuminuria and bodyweight
por: Koomen, Jeroen V., et al.
Publicado: (2018)

Blood pressure‐lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies
por: Olde Engberink, Rik H. G., et al.
Publicado: (2016)

Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in Patients With Type 2 Diabetes
por: Hellemons, Merel E., et al.
Publicado: (2012)

Treating diabetic complications; from large randomized clinical trials to precision medicine
por: Heerspink, Hiddo J. L., et al.
Publicado: (2018)

Novel anti-inflammatory drugs for the treatment of diabetic kidney disease
por: Heerspink, Hiddo J. L., et al.
Publicado: (2016)

Time for clinical decision support systems tailoring individual patient therapy to improve renal and cardiovascular outcomes in diabetes and nephropathy
por: de Zeeuw, Dick, et al.
Publicado: (2020)

Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A post hoc analysis of the IRMA-2 trial
por: Hellemons, Merel E., et al.
Publicado: (2011)

Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709
por: Lambers Heerspink, Hiddo J., et al.
Publicado: (2011)

The Geographical Distribution of Leadership in Globalized Clinical Trials
por: Hoekman, Jarno, et al.
Publicado: (2012)

The Use of Surrogate Endpoints in Regulating Medicines for Cardio-Renal Disease: Opinions of Stakeholders
por: Schievink, Bauke, et al.
Publicado: (2014)

Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatin
por: Kroonen, Marjolein Y. A. M., et al.
Publicado: (2019)

A novel drug response score more accurately predicts renoprotective drug effects than existing renal risk scores
por: Idzerda, Nienke M. A., et al.
Publicado: (2021)

Individual variability in response to renin angiotensin aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: A primary care cohort study
por: Apperloo, Ellen M., et al.
Publicado: (2018)

Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology
por: Waijer, Simke W., et al.
Publicado: (2022)

Proteinuria and cholesterol reduction are independently associated with less renal function decline in statin-treated patients; a post hoc analysis of the PLANET trials
por: Idzerda, Nienke M A, et al.
Publicado: (2019)

Reduction in albuminuria with dapagliflozin cannot be predicted by baseline clinical characteristics or changes in most other risk markers
por: Heerspink, Hiddo J. L., et al.
Publicado: (2018)

Predictors of Progression in Albuminuria in the General Population: Results from the PREVEND Cohort
por: Scheven, Lieneke, et al.
Publicado: (2013)

Improving clinical trial efficiency by biomarker-guided patient selection
por: Boessen, Ruud, et al.
Publicado: (2014)

The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes
por: van Raalte, Daniël H., et al.
Publicado: (2019)

Infancy and Childhood
por: Gorton, David Allyn
Publicado: (1913)

Albuminuria as a marker of systemic congestion in patients with heart failure
por: Boorsma, Eva M, et al.
Publicado: (2022)

Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trial
por: Mosenzon, Ofri, et al.
Publicado: (2020)

DISEASES IN INFANCY AND CHILDHOOD
Publicado: (1951)

DISEASE IN INFANCY AND CHILDHOOD
Publicado: (1956)

SURGERY IN INFANCY AND CHILDHOOD
Publicado: (1958)

PATHOLOGY OF INFANCY AND CHILDHOOD
Publicado: (1960)

DISEASE IN INFANCY AND CHILDHOOD
Publicado: (1960)

SURGERY IN INFANCY AND CHILDHOOD
Publicado: (1968)

SURGERY IN INFANCY AND CHILDHOOD
Publicado: (1974)

DISEASE IN INFANCY AND CHILDHOOD
Publicado: (1963)

DISEASE IN INFANCY AND CHILDHOOD
Publicado: (1966)

Tumours of Infancy and Childhood
por: Pearson, D.
Publicado: (1977)

Diseases of Infancy and Childhood
por: Culotta, Charles S.
Publicado: (1941)

Neurology of infancy and childhood
por: Carter, Sidney, 1912-
Publicado: (1974)

Barrett on Infancy and Childhood
Publicado: (1875)

Convulsions in Infancy and Childhood
Publicado: (1905)

Diseases of Infancy and Childhood
Publicado: (1908)

Cannot write session to /tmp/vufind_sessions/sess_kd50v2na98j887fp33v1bqqmlc